These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15296435)

  • 41. Predictive modeling of protein adsorption along the bed height by taking into account the axial nonuniform liquid dispersion and particle classification in expanded beds.
    Yun J; Lin DQ; Yao SJ
    J Chromatogr A; 2005 Nov; 1095(1-2):16-26. PubMed ID: 16275279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accounting for reasonableness: Exploring the personal internal framework affecting decisions about cancer drug funding.
    Sinclair S; Hagen NA; Chambers C; Manns B; Simon A; Browman GP
    Health Policy; 2008 May; 86(2-3):381-90. PubMed ID: 18243395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hybrid modeling for quality by design and PAT-benefits and challenges of applications in biopharmaceutical industry.
    von Stosch M; Davy S; Francois K; Galvanauskas V; Hamelink JM; Luebbert A; Mayer M; Oliveira R; O'Kennedy R; Rice P; Glassey J
    Biotechnol J; 2014 Jun; 9(6):719-26. PubMed ID: 24806479
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intensified process for the purification of an enzyme from inclusion bodies using integrated expanded bed adsorption and refolding.
    Hutchinson MH; Chase HA
    Biotechnol Prog; 2006; 22(4):1187-93. PubMed ID: 16889397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A knowledge management system for new drug submission by pharma-industries.
    Pinciroli F; Mottadelli S; Vinci M; Fabbro L; Gothager K
    Stud Health Technol Inform; 2004; 107(Pt 1):241-5. PubMed ID: 15360811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expanded bed adsorption as a primary recovery step for the isolation of the insulin precursor MI3 process development and scale up.
    Brixius P; Mollerup I; Jensen OE; Halfar M; Thömmes J; Kula MR
    Biotechnol Bioeng; 2006 Jan; 93(1):14-20. PubMed ID: 16302254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Who has the D? How clear decision roles enhance organizational performance.
    Rogers P; Blenko M
    Harv Bus Rev; 2006 Jan; 84(1):52-61, 131. PubMed ID: 16447369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decision making with an interpretive structural modeling method using a DNA-based algorithm.
    Kim I; Watada J
    IEEE Trans Nanobioscience; 2009 Jun; 8(2):181-91. PubMed ID: 19497835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Managing industrial risk--having a tested and proven system to prevent and assess risk.
    Heller S
    J Hazard Mater; 2006 Mar; 130(1-2):58-63. PubMed ID: 16298053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A computer-aided approach to compare the production economics of fed-batch and perfusion culture under uncertainty.
    Lim AC; Washbrook J; Titchener-Hooker NJ; Farid SS
    Biotechnol Bioeng; 2006 Mar; 93(4):687-97. PubMed ID: 16259001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T-iDT : tool for identification of drug target in bacteria and validation by Mycobacterium tuberculosis.
    Singh NK; Selvam SM; Chakravarthy P
    In Silico Biol; 2006; 6(6):485-93. PubMed ID: 17518759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of physiologically relevant biopharmaceutics tools within the pharmaceutical industry and in regulatory sciences: Where are we now and what are the gaps?
    Flanagan T; Van Peer A; Lindahl A
    Eur J Pharm Sci; 2016 Aug; 91():84-90. PubMed ID: 27283487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early implementation of QbD in biopharmaceutical development: a practical example.
    Zurdo J; Arnell A; Obrezanova O; Smith N; Gómez de la Cuesta R; Gallagher TR; Michael R; Stallwood Y; Ekblad C; Abrahmsén L; Höidén-Guthenberg I
    Biomed Res Int; 2015; 2015():605427. PubMed ID: 26075248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bioprocessing in the Digital Age: The Role of Process Models.
    Narayanan H; Luna MF; von Stosch M; Cruz Bournazou MN; Polotti G; Morbidelli M; Butté A; Sokolov M
    Biotechnol J; 2020 Jan; 15(1):e1900172. PubMed ID: 31486583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Driving drug discovery and patient therapy via the encapsulation and fusion of knowledge.
    Collins MA; Shaw I; Billington DC
    Drug Des Discov; 1999 Nov; 16(3):181-94. PubMed ID: 10624564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Strategic analysis and the drug industry].
    Amédée-Manesme O
    Therapie; 2000; 55(2):313-7. PubMed ID: 10967704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mathematical modelling of expanded bed adsorption - a perspective on in silico process design.
    Koppejan V; Ferreira G; Lin DQ; Ottens M
    J Chem Technol Biotechnol; 2018 Jul; 93(7):1815-1826. PubMed ID: 30008502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Software development for the evaluation of the ergonomic compatibility on the selection of advanced manufacturing technology.
    Maldonado-Macías A; Reyes R; Guillen L; García J
    Work; 2012; 41 Suppl 1():1782-9. PubMed ID: 22316972
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mixing in process vessels used in biopharmaceutical manufacturing.
    Ram K; Vickroy TB; Lamb KA; Slater NK; Dennis JS; Duffy LE
    Biotechnol Prog; 2000; 16(2):244-7. PubMed ID: 10753450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluating end-to-end continuous antibody manufacture with column-free capture alternatives from economic, environmental, and robustness perspectives.
    Neves CPG; Coffman JL; Farid SS
    Biotechnol Prog; 2024 Jan; ():e3427. PubMed ID: 38289674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.